Difference between revisions of "CD106-120"
| (6 intermediate revisions by the same user not shown) | |||
| Line 20: | Line 20: | ||
<tr> | <tr> | ||
<td><strong> CD106</strong></td> | <td><strong> CD106</strong></td> | ||
| − | <td> </td> | + | <td> 100-110</td> |
| − | <td> </td> | + | <td> INCAM-110, vascular cell dehesion molecule-1 (VCAM-1) </td> |
| − | <td> </td> | + | <td> Endothelial cells </td> |
| − | <td> </td> | + | <td> Adhesion molecule that is ligand for VLA-4 </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD107a</strong></td> | <td bgcolor="#cccccc"><strong> CD107a</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 100-120</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Lysosome-associated membrane-protein 1 (LAMP-1) </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Lysosomal membrane, degranulated platelets, PHA-activated T cells, TNF-α-activated endothelium, FMLP-activated neutrophils </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD107b</strong></td> | <td><strong> CD107b</strong></td> | ||
| − | <td> </td> | + | <td> 100-120</td> |
| − | <td> </td> | + | <td> Lysosome-associated membrane-protein 2 (LAMP-2) </td> |
| − | <td> </td> | + | <td> Lysosomal membrane, degranulated platelets, PHA-activated T cells, TNF-α-activated endothelium, FMLP-activated neutrophils </td> |
| − | <td> </td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CDw108</strong></td> | <td bgcolor="#cccccc"><strong> CDw108</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 76</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> John-Milton-Hagen (JHM) human-blood-group antigen </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Lymphocytes, lymphoblasts </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Possible adhesion protein </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD109</strong></td> | <td><strong> CD109</strong></td> | ||
| − | <td> </td> | + | <td> 170</td> |
| − | <td> </td> | + | <td> 8A3, E123 (7D1) </td> |
| − | <td> </td> | + | <td> Activated T cells, activated platelets, vascular endothelium </td> |
| − | <td> </td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD114</strong></td> | <td bgcolor="#cccccc"><strong> CD114</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 150</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> CSF3R, HG-CSFR, granulocyte colony-stimulating factor receptor (G-CSFR) </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> All stages of granulocyte differentiation monocytes, mature platelets, several non-hematopoeitic cell types/tissue including endothelial cells, placenta, trophoblastic cells</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Specific regulator of myeloid proliferation and differentiation</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD115</strong></td> | <td><strong> CD115</strong></td> | ||
| − | <td> </td> | + | <td> 150</td> |
| − | <td> </td> | + | <td> C-fms, colony-stimluating factor 1R (CSF-1R), macrophage colony stimulating factor receptor (M-CSFR) </td> |
| − | <td> </td> | + | <td> Monocytes, macrophages </td> |
| − | <td> </td> | + | <td> Macrophage colony-stimulating factor (M-CSF) receptor </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD116</strong></td> | <td bgcolor="#cccccc"><strong> CD116</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 80</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> GM-CSF receptor α chain </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Various myeloid cells including macrophages, neutrophils, eosinophils, dendritic cells and their precursors </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Primary binding subunit of the GM-CSF receptor </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD117</strong></td> | <td><strong> CD117</strong></td> | ||
| − | <td> </td> | + | <td> 145</td> |
| − | <td> </td> | + | <td> C-KIT, stem cell factor receptor (SCFR) </td> |
| − | <td> </td> | + | <td> Hematopoeitic stem cells and progenitor cells, mast cells </td> |
| − | <td> </td> | + | <td> Growth factor receptor </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CDw119</strong></td> | <td bgcolor="#cccccc"><strong> CDw119</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 90-100</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> IFN-γR, IFN-γRa </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Macrophages, monocytes, B cells, endothelium </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Interferon receptor </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD120a</strong></td> | <td><strong> CD120a</strong></td> | ||
| − | <td> </td> | + | <td> 50-60</td> |
| − | <td> </td> | + | <td> TNFRI, p55 </td> |
| − | <td> </td> | + | <td> Hematopoeitic and non-hematopoeitic cells; highest on epithelial cells </td> |
| − | <td> </td> | + | <td> TNF receptor </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD120b</strong></td> | <td bgcolor="#cccccc"><strong> CD120b</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 75-85</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> TNFRⅡ, p75 </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Hematopoeitic and non-hematopoeitic cells </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> TNF receptor </td> |
</tr> | </tr> | ||
</tbody> | </tbody> | ||
</table> | </table> | ||
Latest revision as of 17:15, 11 September 2006
|
CD antigen |
MW.(kDa) |
Synonyms & Properties |
Leukocyte expression |
Function |
| CD106 | 100-110 | INCAM-110, vascular cell dehesion molecule-1 (VCAM-1) | Endothelial cells | Adhesion molecule that is ligand for VLA-4 |
| CD107a | 100-120 | Lysosome-associated membrane-protein 1 (LAMP-1) | Lysosomal membrane, degranulated platelets, PHA-activated T cells, TNF-α-activated endothelium, FMLP-activated neutrophils | Not known |
| CD107b | 100-120 | Lysosome-associated membrane-protein 2 (LAMP-2) | Lysosomal membrane, degranulated platelets, PHA-activated T cells, TNF-α-activated endothelium, FMLP-activated neutrophils | Not known |
| CDw108 | 76 | John-Milton-Hagen (JHM) human-blood-group antigen | Lymphocytes, lymphoblasts | Possible adhesion protein |
| CD109 | 170 | 8A3, E123 (7D1) | Activated T cells, activated platelets, vascular endothelium | Not known |
| CD114 | 150 | CSF3R, HG-CSFR, granulocyte colony-stimulating factor receptor (G-CSFR) | All stages of granulocyte differentiation monocytes, mature platelets, several non-hematopoeitic cell types/tissue including endothelial cells, placenta, trophoblastic cells | Specific regulator of myeloid proliferation and differentiation |
| CD115 | 150 | C-fms, colony-stimluating factor 1R (CSF-1R), macrophage colony stimulating factor receptor (M-CSFR) | Monocytes, macrophages | Macrophage colony-stimulating factor (M-CSF) receptor |
| CD116 | 80 | GM-CSF receptor α chain | Various myeloid cells including macrophages, neutrophils, eosinophils, dendritic cells and their precursors | Primary binding subunit of the GM-CSF receptor |
| CD117 | 145 | C-KIT, stem cell factor receptor (SCFR) | Hematopoeitic stem cells and progenitor cells, mast cells | Growth factor receptor |
| CDw119 | 90-100 | IFN-γR, IFN-γRa | Macrophages, monocytes, B cells, endothelium | Interferon receptor |
| CD120a | 50-60 | TNFRI, p55 | Hematopoeitic and non-hematopoeitic cells; highest on epithelial cells | TNF receptor |
| CD120b | 75-85 | TNFRⅡ, p75 | Hematopoeitic and non-hematopoeitic cells | TNF receptor |